about
Evaluation of regional antibiograms to monitor antimicrobial resistance in Hampton Roads, VirginiaInfections caused by multidrug resistant organisms are not associated with overall, all-cause mortality in the surgical intensive care unit: the 20,000 foot view.Hospital epidemiology and infection control in acute-care settings.Antibiotic Prescriptions and Prophylaxis in Italian Children. Is It Time to Change? Data from the ARPEC Project.Meta-analysis of experimental data concerning antimicrobial resistance gene transfer rates during conjugationAttributable hospital cost and length of stay associated with health care-associated infections caused by antibiotic-resistant gram-negative bacteria.Multidrug-resistant gram-negative bacteria at a long-term care facility: assessment of residents, healthcare workers, and inanimate surfaces.Factors associated with variation in estimates of the cost of resistant infectionsMultidrug resistant Pseudomonas aeruginosa infection in children undergoing chemotherapy and hematopoietic stem cell transplantation.Antibacterial activity of eravacycline (TP-434), a novel fluorocycline, against hospital and community pathogens.Comparative evaluation of prophylactic single-dose intravenous antibiotic with postoperative antibiotics in elective urologic surgeryClinical and economic consequences of hospital-acquired resistant and multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis.Stop Antibiotics on guidance of Procalcitonin Study (SAPS): a randomised prospective multicenter investigator-initiated trial to analyse whether daily measurements of procalcitonin versus a standard-of-care approach can safely shorten antibiotic durImpact of multidrug-resistant Pseudomonas aeruginosa infection on patient outcomesThe costs of nosocomial resistant gram negative intensive care unit infections among patients with the systemic inflammatory response syndrome- a propensity matched case control studyMicrobial colonization of electrocardiographic telemetry systems before and after cleaningBactericidal Activity of Methanol Extracts of Crabapple Mangrove Tree (Sonneratia caseolaris Linn.) Against Multi-Drug Resistant PathogensMutants resistant to LpxC inhibitors by rebalancing cellular homeostasis.Gram-negative antibiotic resistance: there is a price to pay.Functionalised nanoparticles complexed with antibiotic efficiently kill MRSA and other bacteria.Approaches to the discovery of new antibacterial agents based on bacteriocins.Treatment for infections with carbapenem-resistant Enterobacteriaceae: what options do we still have?Predicting Multidrug-Resistant Gram-Negative Bacterial Colonization and Associated Infection on Hospital Admission.Pharmacokinetic/pharmacodynamic target attainment of intravenous β-lactam regimens against Gram-negative bacteria isolated in a Brazilian teaching hospital.Increased Costs Associated with Bloodstream Infections Caused by Multidrug-Resistant Gram-Negative Bacteria Are Due Primarily to Patients with Hospital-Acquired Infections.Healthcare costs doubled when children had urinary tract infections caused by extended-spectrum β-lactamase-producing bacteria.Potential virulence of Klebsiella sp. isolates from enteral diets.Antibiotic-resistant gram negative bacilli in meals delivered at a general hospital, ItalyImplementation of a procalcitonin-guided algorithm for antibiotic therapy in the burn intensive care unit.Anti-infective Acquisition Costs for a Stewardship Program: Getting to the Bottom Line.Rapid detection of carbapenemase activity through monitoring ertapenem hydrolysis in Enterobacteriaceae with LC-MS/MS.Antimicrobial stewardship programs in pediatrics.A new approach to counteract bacteria resistance: a comparative study between moxifloxacin and a new moxifloxacin derivative in different model systems of bacterial membrane.Procalcitonin-guided antibiotic therapy in intensive care unit patients: a systematic review and meta-analysis.Economic burden of nosocomial infections caused by vancomycin-resistant enterococci.Effect of introducing procalcitonin on antimicrobial therapy duration in patients with sepsis and/or pneumonia in the intensive care unit.Colonization of high-risk children with carbapenemase-producing Enterobacteriaceae in Greece.Source-sink dynamics shape the evolution of antibiotic resistance and its pleiotropic fitness cost.Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial.
P2860
Q28649661-5A55EBEB-F9B1-43F9-B9DF-E84A72F037F5Q30419577-1B961843-A89E-4358-8194-C63F92D20CA7Q30429049-9C5CDF24-891F-4F23-9747-CD5C16644566Q31096335-D54C6715-A110-47FA-A344-982C8977B5D5Q31171989-A8C92A32-7342-4072-AE21-E843A77C8BCDQ33559105-57ADCB6D-F714-4B17-BD79-3112254E4BCCQ33686050-71968324-73B9-4420-B8D4-78E1AEE36F3DQ34077002-289CA01D-A15E-485B-895B-927B96FBAEA4Q34095684-99889EDB-477E-4C0A-A64E-C09C127CCA6AQ34366895-9CA971F0-89DD-4FF0-9B91-70BF04915A72Q34392770-FF60FDC7-4BA4-4F83-A69D-C9F9274F736CQ34446914-DA828047-0917-445B-8393-8C8D12439095Q34670419-DC199FBB-6415-4887-B8BD-8835F5B291ABQ34766191-CDFA6B12-0639-4EAA-9810-8F934B428B76Q35047983-A576AF0D-EC77-4BF4-8404-120BB2708CB5Q35180172-C3C2F39A-093C-4FF7-A824-3EEAE840FD83Q36615727-BAC7A4DE-2329-4A70-BD8E-E0B383B9C482Q36635902-2D311399-10CA-4099-9F02-4E7BEC69D299Q36667930-2E65A44B-B380-4A0F-956B-56BE3E4631C3Q36781180-EB041673-2808-4B6A-8421-81691BCA8A7FQ37149921-A6FC8942-7C71-470C-947C-854BC15270F1Q38231648-392CC2A5-04D3-456E-9A18-D5F66D7BC165Q40067652-FFAFA3CF-2EA2-4DE8-98B4-BB8419BC44DDQ40375664-1BD8079C-7EB0-49F1-91B8-3972A79DA2AFQ40403794-0D7E0722-97F7-4E58-A6A5-AD487EF074D6Q40433736-9451E26D-0014-45C1-9D30-46C18B1F5CF6Q40734886-272D142C-103D-4EC5-8966-51DD3782B1C0Q41809744-8BC07B2F-5374-4F08-8A9F-D47C58A9EBD0Q41944885-65376ED0-EEF8-40BE-A7FF-BEBDAF5B54EBQ41987292-FD5A8BD9-FD06-4732-9620-2441C3B5FC36Q43971402-353F9481-88FB-4445-A487-AD7916BF4459Q45232296-31A0EA7C-90CD-4BD6-B163-56A3D10AC3C9Q46118200-AE6F6598-F867-4672-83C6-69C759B36C28Q47155191-19E1E3C2-C902-403B-B52D-F833F7753546Q47178117-59E11745-211D-490F-AE5B-F8ED27E5E29DQ48544581-9ADBFC28-6773-4AD1-97DD-A4A773041533Q50934594-21AB0C39-8904-40D0-B07A-03349015B194Q51705053-9349EBC8-BFA4-485C-AB15-A6B431D64BD4Q51898034-3E547500-65E1-4B88-9E09-5A2384030F00
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Cost of Gram-negative resistance.
@ast
Cost of Gram-negative resistance.
@en
type
label
Cost of Gram-negative resistance.
@ast
Cost of Gram-negative resistance.
@en
prefLabel
Cost of Gram-negative resistance.
@ast
Cost of Gram-negative resistance.
@en
P2093
P50
P1476
Cost of Gram-negative resistance.
@en
P2093
Alison R Schulman
Daniel P Raymond
Jason Lyman
Michael G Hughes
Shannon T McElearney
Shayna N Lefrak
Tae W Chong
P356
10.1097/01.CCM.0000251496.61520.75
P407
P577
2007-01-01T00:00:00Z